| Literature DB >> 30096918 |
Craig L Frank1, Katherine G Sitler-Elbel2, Anna J Hudson3, Melissa R Ingala4.
Abstract
Numerous free fatty acids (FFAs) are known to have potent antifungal effects. The mammalian epidermis contains both FFAs and multiple classes of fatty acid esters, including 1-monoacylglycerols and wax esters. We thus hypothesized that wax esters and 1-monoacylglycerols composed of antifungal fatty acids would also have antifungal properties. We tested this hypothesis by examining the effects of 1-monoacylglycerols, 1,3-diacylglycerols, and wax esters on the growth of Pseudogymnoascus destructans (Pd), the fungus that causes White-nose Syndrome (WNS) in North American bats by invading their epidermis. Laboratory experiments with Pd cultures demonstrated that: (a) three 1-monoacylglycerols (1-monopalmitolein, 1-monoolein, and 1-monolinolein), as well as, (b) two wax esters, behenyl oleate and behenyl palmitoleate, profoundly inhibit Pd growth. The normal growth cycle of Pd was interrupted by addition of two cholesterol esters to the media as well. A bat species resistant to cutaneous Pd infections has these 1-monoacylglycerols in the epidermis, and another Pd resistant bat species has these wax esters in the sebum, thus cutaneous lipid composition is one factor which enables some bats to avoid WNS. Our experiments also revealed that the fatty acid esters which inhibit Pd growth are not hydrolyzed by the lipases secreted by this fungus, whereas the esters that do not inhibit Pd growth are hydrolyzed.Entities:
Keywords: 1,3-diacylglycerol; 1-monoacylglycerol; Free Fatty Acid (FFA); P. destructans; antifungal effects; bats; epidermis; hibernation; sebum; wax ester
Mesh:
Substances:
Year: 2018 PMID: 30096918 PMCID: PMC6222711 DOI: 10.3390/molecules23081986
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1Mean (± SE) surface areas of Pseudogymnoascus destructans colonies at various stages of growth in: (A) Experiment 1, and (B) Experiment 2 at Ta = 5.3 (blue symbols) and 10.3 °C (red symbols). Means within the same Ta treatment and experiment sharing a common lower-case letter are not significantly different at the p < 0.05 level.
Figure 2Mean (± SE) surface areas of Pseudogymnoascus destructans colonies at various stages of growth in: (A) Experiment 3, and, (B) Experiment 4 at Ta = 5.5–6.4 (blue symbols) and 10.1–11.5 °C (red symbols). Means within the same Ta treatment and experiment sharing a common lower-case letter are not significantly different at the p < 0.05 level.
Figure 3Mean (± SE) surface areas of Pseudogymnoascus destructans colonies at various stages of growth in: (A) Experiment 5, and (B) Experiment 6 at Ta = 4.9–5.7 (blue symbols) and 10.4 °C (red symbols). Means within the same Ta treatment and experiment sharing a common lower-case letter are not significantly different at the p < 0.05 level.
Mean (± SE) % of control colony area for each media treatment that significantly affected Pd growth in Experiments 1–5.
| Temperature (°C) | Media Composition | % Control Colony Area |
|---|---|---|
| 4.9–6.9 | 0.2% Linoleic Acid | 37.3 ± 1.2 a* |
| 0.2% 1-Monoolein | 70.4 ± 4.1 b | |
| 0.2% Behenyl Oleate | 56.5 ± 10.5 a | |
| 0.2% Behenyl Palmitoleate | 15.5 ± 7.7 c | |
| 10.1–11.5 | 0.2% Linoleic Acid | 65.7 ± 4.4 a |
| 0.2% 1-Monoolein | 82.7 ± 8.1 a | |
| 0.2% 1-Monopalmitolein | 68.7 ± 9.2 a | |
| 0.2% 1-Monolinolein | 51.8 ± 8.0 a | |
| 0.2% Behenyl Oleate | 58.1 ± 10.2 a | |
| 0.2% Behenyl Palmitoleate | 9.6 ± 6.7 b |
* Means sharing a common lower-case letter within the same temperature category are not significantly different at the p < 0.05 level.
Figure 4Photographs of Pseudogymnoascus destructans colonies after 19 d of growth at 12.7 °C in Experiment 6 on the control, 1.0% tributyrin, 1.0% 1-monoacylglycerol, and 1.0% cholesterol ester media.
Media, ambient temperature (Ta), and sample size (N) for the P. destructans growth experiments.
| Experiment | Media Composition | Low Ta (°C) | N | High Ta (°C) | N |
|---|---|---|---|---|---|
| 1 | Control | 5.3 | 16 | 10.3 | 22 |
| 0.2% DG(16:1/0:0/16:1) | 5.3 | 22 | 10.3 | 16 | |
| 0.2% DG(18:2/0:0/18:2) | 5.3 | 22 | 10.3 | 17 | |
| 2 | Control | 5.3 | 19 | 10.3 | 17 |
| 0.2% MG(16:1/0:0/0:0) | 5.3 | 19 | 10.3 | 11 | |
| 0.2% MG(18:2/0:0/0:0) | 5.3 | 21 | 10.3 | 19 | |
| 3 | Control | 6.9 | 20 | 11.5 | 20 |
| 0.2% MG(18:1/0:0/0:0) | 6.9 | 20 | 11.5 | 18 | |
| 0.2% MG(16:0/0:0/0:0) | 6.9 | 20 | 11.5 | 15 | |
| 0.2% MG(18:0/0:0/0:0) | 6.9 | 20 | 11.5 | 18 | |
| 4 | Control | 5.5 | 19 | 10.1 | 18 |
| 0.2% WE(22:0/18:1) | 5.5 | 19 | 10.1 | 20 | |
| 0.2% WE(22:0/16:1) | 5.5 | 20 | 10.1 | 16 | |
| 5 | Control | 4.9 | 9 | 10.4 | 12 |
| 0.2% C18:2Δ9,12 | 4.9 | 15 | 10.4 | 12 | |
| 0.5% C18:2Δ9,12 | 4.9 | 16 | 10.4 | 9 | |
| 6 | Control | 5.7 | 21 | 12.7 | 18 |
| 1.0% TG(4:0/4:0/4:0) | 5.7 | 17 | 12.7 | 18 | |
| 1.0% Cholesterol Esters | 5.7 | 19 | 12.7 | 19 | |
| 1.0% 1-Monoacylglycerols | 5.7 | 18 | 12.7 | 17 |